Viiv Healthcare Recalls Tivicay Tablets Due to Cross-Contamination with Promacta
Viiv Healthcare is recalling 1,056 bottles of Tivicay (dolutegravir) 50 mg tablets because they were found to contain Promacta (eltrombopag). The recall covers products distributed nationwide, including Puerto Rico.
- Product
- TIVICAY — TIVICAY (DOLUTEGRAVIR SODIUM)
- Category
- Drug
- Distribution
- Distributed nationwide